Walleye Capital’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-21,621
| Closed | -$364K | – | 2293 |
|
|
2024
Q4 | $364K | Buy |
+21,621
| New | +$364K | ﹤0.01% | 1292 |
|
|
2022
Q2 | – | Sell |
-104,906
| Closed | -$3.14M | – | 2619 |
|
|
2022
Q1 | $3.14M | Buy |
104,906
+31,976
| +44% | +$956K | 0.08% | 238 |
|
|
2021
Q4 | $1.93M | Buy |
+72,930
| New | +$1.93M | 0.06% | 328 |
|
|
2020
Q3 | – | Sell |
-2,900
| Closed | -$53K | – | 939 |
|
|
2020
Q2 | $53K | Buy |
+2,900
| New | +$53K | 0.01% | 543 |
|
|
2018
Q3 | $488K | Buy |
+15,192
| New | +$488K | 0.23% | 119 |
|